Phytochemicals in the Treatment of Alzheimer’s Disease: A Systematic Review


Journal Name: Current Drug Targets

Volume 18 , Issue 13 , 2017

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Background: Alzheimer's disease (AD) is the most widespread age-related neurodegenerative disease. Recently, a growing body of evidence suggested the phytochemical use to slow down AD onset and progression.

Objective: To review the phytochemical role potentially involved in AD treatment.

Method: A systematic review from existing literature on phytochemicals used in the treatment of AD patients was conducted. Selection criteria included: 1) age≥60 years; 2) AD diagnosis in agreement with the criteria of National Institute on Aging-Alzheimer's Association (NIAAA), and 3) suitable measures to asses cognitive, functional and clinical status.

Results: Ninety-seven articles were involved in the present study. Several phytochemicals seem to slow down AD onset, delay disease progression and let recovery through targeting multiple pathological causes by anti-cholinergic, antioxidant and anti-inflammatory features.

Conclusion: Deeper knowledge on phytochemicals and their specific molecular targets is essential to guarantee safe use of these compounds as an option for AD treatment.

Keywords: Phytochemicals, Alzheimer's disease, antioxidant properties, anti-inflammatory activities, acetilcholinesterase inhibitors, AChEIs.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2017
Published on: 14 September, 2017
Page: [1487 - 1498]
Pages: 12
DOI: 10.2174/1389450117666161102121553
Price: $65

Article Metrics

PDF: 28